Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation
Crossref DOI link: https://doi.org/10.1007/s00432-015-2050-y
Published Online: 2015-09-30
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pfrepper, Christian
Klink, Anne
Behre, Gerhard
Schenk, Thomas
Franke, Georg-Nikolaus
Jentzsch, Madlen
Schwind, Sebastian
Al-Ali, Haifa-Kathrin
Hochhaus, Andreas
Niederwieser, Dietger
Sayer, Herbert Gottfried
Text and Data Mining valid from 2015-09-30